Increasing yields and improving safety on the production line.
Thanks to advances in minimally invasive catheter-based procedures, structural heart diseases are now often treated through endovascular therapy. However, manufacturing structural heart catheters is not without its challenges, particularly when it comes to the final stage in production, the removal of heat shrink.
A skiving tool containing a razor blade is typically used to remove the heat shrink from the catheter. However, this is a time-intensive process that is prone to error. Critical damage to the catheter is common, and using razor blades on the production line presents a serious safety risk to operators when trying to work at speed.
Download this publication to learn how OEMs are embracing an innovative solution to significantly improve their production processes and ability to support the demand or the widening use of catheters when treating structural heart disease.